Prasanth Subramanian, Venkataraman Prabhu, A. Ramachandran, J. Kumar
{"title":"A Cross-Sectional Study to Determine the Prevalence and Predictors of Depression and Anxiety in Type 2 Diabetes Patients in South India","authors":"Prasanth Subramanian, Venkataraman Prabhu, A. Ramachandran, J. Kumar","doi":"10.4103/ijnpnd.ijnpnd_83_23","DOIUrl":null,"url":null,"abstract":"Diabetic patients with depression or anxiety are more likely to develop diabetic complications and have a lower quality of life. The aim of the study is to determine the prevalence of depression and anxiety among type 2 diabetic patients and to identify the associated factors. A cross-sectional, observational study of type 2 diabetes mellitus outpatients, with diabetes-related conditions who attended the hospital from January to April 2023, was conducted by interviewing them using the Patient Health Questionnaire-9 for depression and Generalised Anxiety Disorders-7 for anxiety. Descriptive statistics, bivariate analysis, and multivariant regression were performed for statistical analysis. Out of 450 type 2 diabetic patients, 90% were between ages 30 and 45, 50.2% were male, 60% were living in rural areas, and 76.5% literate; most of them belong to the upper middle class (64%) and they live in joint family (32.7%). Depression and anxiety were observed among 65.3% and 62.4% of type 2 diabetic patients, respectively. When observing the severity, 47.8% of patients had mild depression, and 38.7% had minimal anxiety. Age group, socioeconomic status, treatment type, and years of diabetes were found to be factors associated with depression and family type is associated with anxiety. Hospitalized diabetics have higher depression and anxiety rates for multiple reasons. Therefore, diabetes management programmes should include regular depression and anxiety screenings to quickly identify and treat high-risk patients in healthcare facilities.","PeriodicalId":14233,"journal":{"name":"International Journal of Nutrition, Pharmacology, Neurological Diseases","volume":"3 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nutrition, Pharmacology, Neurological Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijnpnd.ijnpnd_83_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Diabetic patients with depression or anxiety are more likely to develop diabetic complications and have a lower quality of life. The aim of the study is to determine the prevalence of depression and anxiety among type 2 diabetic patients and to identify the associated factors. A cross-sectional, observational study of type 2 diabetes mellitus outpatients, with diabetes-related conditions who attended the hospital from January to April 2023, was conducted by interviewing them using the Patient Health Questionnaire-9 for depression and Generalised Anxiety Disorders-7 for anxiety. Descriptive statistics, bivariate analysis, and multivariant regression were performed for statistical analysis. Out of 450 type 2 diabetic patients, 90% were between ages 30 and 45, 50.2% were male, 60% were living in rural areas, and 76.5% literate; most of them belong to the upper middle class (64%) and they live in joint family (32.7%). Depression and anxiety were observed among 65.3% and 62.4% of type 2 diabetic patients, respectively. When observing the severity, 47.8% of patients had mild depression, and 38.7% had minimal anxiety. Age group, socioeconomic status, treatment type, and years of diabetes were found to be factors associated with depression and family type is associated with anxiety. Hospitalized diabetics have higher depression and anxiety rates for multiple reasons. Therefore, diabetes management programmes should include regular depression and anxiety screenings to quickly identify and treat high-risk patients in healthcare facilities.
期刊介绍:
The International Journal of Nutrition, Pharmacology, Neurological Diseases (IJNPND) is an international, open access, peer reviewed journal which covers all fields related to nutrition, pharmacology, neurological diseases. IJNPND was started by Dr. Mohamed Essa based on his personal interest in Science in 2009. This journal doesn’t link with any society or any association. The co-editor-in chiefs of IJNPND (Prof. Gilles J. Guillemin, Dr. Abdur Rahman and Prof. Ross grant) and editorial board members are well known figures in the fields of Nutrition, pharmacology, and neuroscience. First, the journal was started as two issues per year, then it was changed into 3 issues per year and since 2013, it publishes 4 issues per year till now. This shows the slow and steady growth of this journal. To support the reviewers and editorial board members, IJNPND offers awards to the people who does more reviews within one year. The International Journal of Nutrition, Pharmacology, Neurological Diseases (IJNPND) is published Quarterly. IJNPND has three main sections, such as nutrition, pharmacology, and neurological diseases. IJNPND publishes Research Papers, Review Articles, Commentaries, case reports, brief communications and Correspondence in all three sections. Reviews and Commentaries are normally commissioned by the journal, but consideration will be given to unsolicited contributions. International Journal of Nutrition, Pharmacology, Neurological Diseases is included in the UGC-India Approved list of journals.